Transcriptomic responses of the human kidney to acute injury at single cell resolution
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Background
Acute kidney injury (AKI) occurs frequently in critically ill patients and is associated with adverse outcomes. Cellular mechanisms underlying AKI and kidney cell responses to injury remain incompletely understood.
Methods
We performed single-nuclei transcriptomics, bulk transcriptomics, molecular imaging studies, and conventional histology on kidney tissues from 8 individuals with severe AKI (stage 2 or 3 according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria). Specimens were obtained within 1-2 hours after individuals had succumbed to critical illness associated with respiratory infections, with 4 of 8 individuals diagnosed with COVID-19. Control kidney tissues were obtained post-mortem or after nephrectomy from individuals without AKI.
Results
High-depth single cell-resolved gene expression data of human kidneys affected by AKI revealed enrichment of novel injury-associated cell states within the major cell types of the tubular epithelium, in particular in proximal tubules, thick ascending limbs and distal convoluted tubules. Four distinct, hierarchically interconnected injured cell states were distinguishable and characterized by transcriptome patterns associated with oxidative stress, hypoxia, interferon response, and epithelial-to-mesenchymal transition, respectively. Transcriptome differences between individuals with AKI were driven primarily by the cell type-specific abundance of these four injury subtypes rather than by private molecular responses. AKI-associated changes in gene expression between individuals with and without COVID-19 were similar.
Conclusion
The study provides an extensive resource of the cell type-specific transcriptomic responses associated with critical illness-associated AKI in humans, highlighting recurrent disease-associated signatures and inter-individual heterogeneity. Personalized molecular disease assessment in human AKI may foster the development of tailored therapies.
Article activity feed
-
SciScore for 10.1101/2021.12.15.472619: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization The training set included randomly selected cells (2/3 of cells) from injured mouse PT subclusterings (Suppl. Fig. S6) Blinding not detected. Power Analysis not detected. Table 2: Resources
Recombinant DNA Sentences Resources ), Newark, CA) was used to perform chromogenic in situ hybridization on formalin-fixed paraffin embedded mouse kidney sections with probes directed against IFITM3 (#1062531-C1, ACD), IGFBP7 (#316681, ACD) and IL18 (#400301, ACD). #1062531-C1suggested: NoneSoftware and Algorithms Sentences Resources Provided FASTQ files were aligned using STAR and the same genome as for the snRNA-seq data (GRCh38 3.0.0 with … SciScore for 10.1101/2021.12.15.472619: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics not detected. Sex as a biological variable not detected. Randomization The training set included randomly selected cells (2/3 of cells) from injured mouse PT subclusterings (Suppl. Fig. S6) Blinding not detected. Power Analysis not detected. Table 2: Resources
Recombinant DNA Sentences Resources ), Newark, CA) was used to perform chromogenic in situ hybridization on formalin-fixed paraffin embedded mouse kidney sections with probes directed against IFITM3 (#1062531-C1, ACD), IGFBP7 (#316681, ACD) and IL18 (#400301, ACD). #1062531-C1suggested: NoneSoftware and Algorithms Sentences Resources Provided FASTQ files were aligned using STAR and the same genome as for the snRNA-seq data (GRCh38 3.0.0 with SARS-CoV1/2), reads were then counted using featureCounts57 with -p -t exon -O -g gene_id -s 0. STARsuggested: (STAR, RRID:SCR_004463)Differential gene expression analysis: Differential gene expression analysis was performed using the DESeq2 pacakge (version 1.28.1). DESeq2suggested: (DESeq, RRID:SCR_000154)DESeq dataset was generated by: dds <- DESeqDataSetFromMatrix(countData = my.count.data, colData = col.data, design = ∼ condition + perc.mt), followed by: dds <- estimateSizeFactors(dds, type=‘poscounts’) dds <- DESeq(dds) “condition” was either AKI or control, my.count. DESeqsuggested: (DESeq, RRID:SCR_000154)Pathway enrichment analysis: Differentially expressed genes were analyzed, separately, for genes up- and downregulated in AKI versus controls using the MSigDB web interface: http://www.gsea-msigdb.org/gsea/msigdb/annotate.jsp with the hallmark gene sets and curated gene sets (C1) from Biocarta, Biocartasuggested: (BioCarta Pathways, RRID:SCR_006917)Kegg, Reactome and WikiPathways Reactomesuggested: (Reactome, RRID:SCR_003485)WikiPathwayssuggested: (WikiPathways, RRID:SCR_002134)Multinomial classification was performed using the glmnet package version 2.0-16. glmnetsuggested: (glmnet, RRID:SCR_015505)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:These findings suggest that precision approaches like single cell transcriptomics maybe suitable tools to overcome the current limitations in diagnosing and treating subtypes of AKI.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-